Compare TARS & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TARS | PFS |
|---|---|---|
| Founded | 2016 | 1839 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.7B |
| IPO Year | 2020 | 2002 |
| Metric | TARS | PFS |
|---|---|---|
| Price | $60.71 | $22.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $89.00 | $23.75 |
| AVG Volume (30 Days) | 614.2K | ★ 741.6K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.28% |
| EPS Growth | 48.21 | ★ 112.38 |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $451,360,000.00 | $73,109,000.00 |
| Revenue This Year | $56.43 | $0.68 |
| Revenue Next Year | $30.19 | $5.97 |
| P/E Ratio | ★ N/A | $36.72 |
| Revenue Growth | ★ 146.71 | 7.06 |
| 52 Week Low | $38.51 | $15.92 |
| 52 Week High | $85.25 | $23.98 |
| Indicator | TARS | PFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 52.27 |
| Support Level | $60.38 | $21.53 |
| Resistance Level | $67.24 | $22.96 |
| Average True Range (ATR) | 3.45 | 0.41 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 34.38 | 63.95 |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.